INS and neoplasm: The results of the current study demonstrated that 10-years continuous PEG treatment results in disease control in almost all acromegalic patients resistant to SRLs, with a prolonged beneficial impact on insulin, and lipid metabolism, without tachyphylaxis and negative effects on tumour growth.